Fri, Dec 26, 2014, 2:49 AM EST - U.S. Markets open in 6 hrs 41 mins


% | $
Quotes you view appear here for quick access.

SIGA Technologies, Inc. Message Board

nicehedges 12 posts  |  Last Activity: Nov 21, 2014 6:48 AM Member since: Feb 15, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    BAM!!!! The VA resumed orders!

    by oosetrain760 Nov 20, 2014 2:00 PM
    nicehedges nicehedges Nov 21, 2014 6:48 AM Flag

    excellent find oose! this sort of validation is HUGE!

  • Reply to

    Schedule 13D out this morning

    by nicehedges Nov 12, 2014 6:44 AM
    nicehedges nicehedges Nov 16, 2014 5:49 AM Flag

    Still no form 4.... interesting.

  • Reply to

    Schedule 13D out this morning

    by nicehedges Nov 12, 2014 6:44 AM
    nicehedges nicehedges Nov 12, 2014 9:01 AM Flag

    about 375k has traded since the last form 4. I don't know if they are required to file a form 4 if the change in ownership is reflected on a 13g. I would imagine that a form 4 is always required to cover the detail of the transaction. What is for sure is a whale, with intimate knowledge of Siga's inner workings, is loading up on the open market.

  • From the Form 4 from a few days ago, the "Amount of Securities Beneficially Owned Following Reported Transaction(s)" showed as 13,509,722 as of 11/7. From this morning's 13D "Aggregate Amount Beneficially Owned by Each Reporting Person" is listed at 13,759,722 with Percent of Class now standing at 25.6%. This reads as mafco being behind the purchase of 250k additional shares over the last few days.

  • Reply to

    Ronnie Doubles Down Again!!!!

    by beepoe111 Nov 10, 2014 8:21 PM
    nicehedges nicehedges Nov 10, 2014 8:48 PM Flag

    Chump change for him, but at least someone at the co is buying.

  • Reply to

    SIGA and PIP Headed to Mediation

    by sellhighdrinklow Oct 31, 2014 12:43 PM
    nicehedges nicehedges Oct 31, 2014 5:30 PM Flag

    interesting turn of events and up a bit on this news. Here is Bloomberg's take on it:
    Smallpox Drug Maker Siga to Mediate PharmAthene Dispute
    By Erik Larson October 31, 2014
    Siga Technologies Inc. (SIGA:US), the biological-warfare defense firm supplying the only smallpox drug for the U.S. strategic stockpile, got court permission to mediate a damages award in a licensing dispute that drove it into bankruptcy.
    Siga and competitor PharmAthene Inc. (PIP:US), which won a 2006 lawsuit, agreed to mediate a final resolution over the amount of damages Siga must pay, U.S. Bankruptcy Judge Sean Lane said in a ruling yesterday in Manhattan. A creditor committee that includes PharmAthene had supported mediation, according to court papers.
    The litigation, pending in Delaware state court, will continue during mediation, and any accord over a possible $232 million in damages reached by the companies will require bankruptcy court approval, Lane said.
    Delaware’s highest court last year upheld a judge’s 2011 finding that Siga violated promises to negotiate in good faith with Annapolis, Maryland-based PharmAthene over a license for Tecovirimat when it was being developed. Siga may have walked away from the talks after realizing the drug’s potential value, the court ruled.
    Tecovirimat, an antiviral drug, is intended for use during a possible biological terrorist attack and the U.S. needs the product, New York-based Siga said. The company filed for court protection from creditors on Sept. 16, saying the damages award in the lawsuit may imperil its operations.
    Filing for bankruptcy allowed Siga to put off posting a court bond on the damages award while attempting to lower the penalty on appeal, Siga said in court filings.
    Siga’s chief executive officer, Eric Rose, has said in court papers that his company is committed to fulfilling a contract with the U.S., the total value of which is about $463 million. The deal, struck in 2011, calls for 2 million doses of the smallpox drug, also known as Arestvyr, and 1.3 million have already been delivered, Rose said in September.

    Smallpox, is a sometimes-lethal airborne virus as infectious as the common flu. Siga’s drug is the only known viable treatment, the company said.

    Siga won the government contract through a unit of the U.S. Department of Health and Human Services, which was authorized by Congress under the Project BioShield Act of 2004 to acquire drugs in the national interest, even if they haven’t been approved by regulators, according to Siga’s court filing.

  • Reply to

    NYT:Resurrecting Smallpox? Easier Than You Think

    by nicehedges Oct 16, 2014 5:59 AM
    nicehedges nicehedges Oct 17, 2014 1:15 PM Flag

    I do remember... wow that feels like an eternity ago, and still we do not have a clear path forward for FDA approval.
    Every so often I yap about this "synthetic potential" and now years later the NYT decides to write about it. I suppose with Ebola and ISIS in the news now this a logical article to see in print. ISIS is the ideal group to see hiring a foundry to whip up a batch for their destructive conquests. They would salivate at the idea of launching this kind of attack on the mainland US. In the Ebola fiasco we clearly see that our gov't is unprepared for an outbreak. A bad mix of political correctness and hubris has left us with a scatterbrained response thus far. I have yet to hear a sensible explanation as to why we have not secured our borders or at the least instituted a commercial travel ban.

  • Haven't seen this kind of size in a while.

  • Reply to

    NYT:Resurrecting Smallpox? Easier Than You Think

    by nicehedges Oct 16, 2014 5:59 AM
    nicehedges nicehedges Oct 16, 2014 6:22 AM Flag

    Author of this article, Leonard Adleman just grasped what we have been discussing on this board for years....The Synthetic Potential. Genomic Foundries are out there and groups like ISIS are sophisticated, capitalized, and sick enough to use them to deliver this nightmare scenario, especially after seeing how unprepared and scatter brained the CDC is in their response to Ebola.

  • "...If you search online, you can find the sequence for the smallpox genome. It is a word written with the letters A, T, C and G. The word is about 185,000 letters long. It is the word that tells cells to make smallpox viruses. The sequence was stored on a computer in the early 1990s, when a research team led by J. Craig Venter obtained it using a biotechnical process applied to a sample of the virus.
    Of course, a word in a computer file cannot kill you. Well, yes and no. In the 1990s, I ran a biotechnology laboratory. In my lab there was a machine much like a soda dispenser, only in this case the reservoirs were filled with chemicals. If I typed in a short word of my choice using the letters A, T, C and G, the machine would squirt one chemical after another into a test tube. When it was done, the test tube would contain trillions of molecules of DNA. Each would look like a necklace, with molecules of adenine, thymine, cytosine and guanine (the building blocks of DNA) strung according to the word I had typed.
    At that time, the 10,000-letter sequence of the H.I.V. genome was available online. I contemplated using my machine, together with well-known biotechnical methods, to create, de novo, the H.I.V. genome — an actual molecule identical to that found in H.I.V. viruses living in the wild. I had reason to believe that inserting such a synthetic molecule into a living human cell would cause the cell to manufacture full-blown H.I.V. viruses that could then be transmitted from person to person and cause AIDS...."

  • nicehedges nicehedges Oct 6, 2014 8:54 PM Flag

    CMX001 is starting to look like the Silver Bullet we had hoped for in ST-669 back when Siga was still a motivated research and development company. CMRX traded at 52 week highs today on this news at over 10x average volume.
    The last I heard Duncan was in very bad shape. If CMX001 brings him back from the brink, and assuming it works as well on smallpox, this would be yet another reason for BARDA to weight its purchase over ST-246...that is, if they are still planning on procuring the follow on courses that Chimerix protested Siga initially being awarded. Parsons' non-speculative assessment of ST-246 is looking more and more speculative by the day, as alternatives for the stockpile look more and more attractive.

  • Reply to

    Ronnie Pearlman Doubling Down

    by beepoe111 Sep 25, 2014 9:27 PM
    nicehedges nicehedges Sep 26, 2014 7:04 AM Flag

    Too cheap for Ronnie P to ignore. If you believe a common sense ruling will come out of the DSC, it is difficult to ignore these prices. I may have to follow the money here.

1.43-0.03(-2.05%)Dec 24 1:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Amira Nature Foods Ltd.
NYSEWed, Dec 24, 2014 1:04 PM EST